Eli Lilly CEO Dave Ricks said one-third of new GLP-1 pill patients are taking Foundayo as the company breaks ground on a $6.5 billion Houston plant that will make the obesity pill and other medicines.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
